System for providing fluid flow to nerve tissues
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-017/08
A61F-013/00
A61B-017/11
A61M-001/00
출원번호
US-0252664
(2014-04-14)
등록번호
US-8998934
(2015-04-07)
발명자
/ 주소
Swain, Larry D.
Manwaring, Michael E.
Cornet, Douglas A.
Leung, Braden K.
출원인 / 주소
KCI Licensing, Inc.
인용정보
피인용 횟수 :
0인용 특허 :
89
초록▼
Provided is an apparatus that includes a nerve conduit and a nested manifold for providing a reduced pressure. Also provided is a system that includes a source of reduced pressure, a nerve conduit and nested manifold, and a conduit for providing fluid communication between the manifold and the sourc
Provided is an apparatus that includes a nerve conduit and a nested manifold for providing a reduced pressure. Also provided is a system that includes a source of reduced pressure, a nerve conduit and nested manifold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above nerve conduit and manifold at a site of damaged nerve tissue and applying a reduced pressure to the manifold thereby stimulating repair or regrowth of nerve tissue.
대표청구항▼
1. An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising: a nerve conduit having a luminal wall for surrounding the tissue site and forming a luminal space between the tissue site and the luminal wall;a manifold having a connector for receiving
1. An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising: a nerve conduit having a luminal wall for surrounding the tissue site and forming a luminal space between the tissue site and the luminal wall;a manifold having a connector for receiving reduced pressure to distribute the reduced pressure to the defect; anda scaffold formed from a bioabsorbable material, the scaffold having: pores that are sufficiently small to bind cells and proteins,a generally tubular frustum shape extending between a base opening at one end and a vertex opening at the other end,at least one fiber guide extending through the luminal space and the vertex opening of the scaffold that is adapted to be in fluid communication with the tissue site of the nerve, andthe scaffold being positioned within the luminal space with the vertex opening oriented closer to the manifold. 2. The apparatus of claim 1, wherein the defect is a severed nerve. 3. The apparatus of claim 1, wherein the defect is a pinched, partially severed, or degenerative nerve extending through the vertex opening of the scaffold. 4. The apparatus of claim 1, wherein the scaffold is composed of a hydrophobic or a hydrophilic material. 5. The apparatus of claim 1, wherein the at least one fiber guide is in fluid communication with the manifold and the scaffold. 6. The apparatus of claim 1, wherein the at least one fiber guide comprises fibrous protrusions extending into the luminal space. 7. The apparatus of claim 1, wherein the at least one fiber guide is generally linear. 8. The apparatus of claim 1, wherein the at least one fiber guide is bioabsorbable. 9. The apparatus of claim 8, wherein the at least one fiber guide is comprised of collagen or fibrin. 10. The apparatus of claim 1, wherein the manifold is positioned adjacent the distal side of the nerve. 11. The apparatus of claim 1, wherein the manifold provides reduced pressure preferentially to the distal side of the nerve. 12. The apparatus of claim 1, wherein the manifold is composed of a bioinert or bioabsorbable material. 13. The apparatus of claim 1, wherein the manifold is substantially tubular or cylindrical in shape and positioned within the luminal space. 14. The apparatus of claim 1, wherein the manifold extends through the wall of the nerve conduit in fluid communication with the luminal space. 15. The apparatus of claim 1, wherein the scaffold is formed from a foam or gel material. 16. The apparatus of claim 1, wherein the scaffold comprises a bioactive agent. 17. The apparatus of claim 16, wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor. 18. The apparatus of claim 16, wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF). 19. The apparatus of claim 1, wherein the nerve conduit comprises a slice along its length that forms an opening whereby the nerve conduit is implantable around the tissue site and sealable with one or more closure elements. 20. The apparatus of claim 1, wherein the nerve conduit is composed of a bioinert material. 21. The apparatus of claim 1, wherein the nerve conduit is composed of a bioabsorbable material. 22. The apparatus of claim 21, wherein the nerve conduit is composed of collagen. 23. The apparatus of claim 1, wherein the nerve conduit comprises pores. 24. The apparatus of claim 23, wherein the pores are sufficiently small to exclude the entry of cells from tissue surrounding the nerve conduit into the luminal space. 25. The apparatus of claim 24, wherein the pores have a diameter of between about 5 μm and about 50 μm. 26. The apparatus of claim 1, wherein the manifold is in fluid communication with the scaffold. 27. An apparatus for providing reduced pressure to a defect at a tissue site of a nerve, the apparatus comprising: a nerve conduit having a generally tubular shape and having a luminal wall for surrounding the tissue site to contain fluids within a luminal space between the tissue site and the luminal wall;a manifold having a connector for receiving reduced pressure to distribute the reduced pressure to the defect; anda scaffold formed from a bioabsorbable material and comprising: at least one scaffold guide having pores that are sufficiently small to collect cells and a generally frusto-tubular shape with a base opening at one end and a vertex opening at the other end, the at least one scaffold guide is positioned within the luminal space in fluid communication with the manifold and oriented therein with the vertex opening positioned closer to the manifold than the base opening,at least one fiber guide extending generally longitudinally through the luminal space and the vertex opening of the at least one scaffold guide and is adapted to be in fluid communication with the tissue site of the nerve;whereby the at least one scaffold guide facilitates tissue growth at the tissue site by organizing matrix deposition, promoting cell binding, or guiding the migration of cells through the luminal space. 28. The apparatus of claim 27, wherein the defect is a severed nerve. 29. The apparatus of claim 27, wherein the defect is a pinched, partially severed, or degenerative nerve extending through the vertex opening of the at least one scaffold guide. 30. The apparatus of claim 27, wherein the at least one scaffold guide is composed of a hydrophobic material. 31. The apparatus of claim 27, wherein the at least one fiber guide is in fluid communication with the manifold and the at least one scaffold guide. 32. The apparatus of claim 27, wherein the at least one fiber guide comprises fibrous protrusions extending into the luminal space. 33. The apparatus of claim 27, wherein the at least one fiber guide is generally linear. 34. The apparatus of claim 27, wherein the at least one fiber guide is bioabsorbable. 35. The apparatus of claim 34, wherein the at least one fiber guide is comprised of collagen or fibrin. 36. The apparatus of claim 27, wherein the manifold is positioned adjacent the distal side of the nerve. 37. The apparatus of claim 27, wherein the manifold provides reduced pressure preferentially to the distal side of the nerve. 38. The apparatus of claim 27, wherein the manifold is composed of a bioinert or bioabsorbable material. 39. The apparatus of claim 27, wherein the manifold is substantially tubular or cylindrical in shape and positioned within the luminal space of the nerve conduit. 40. The apparatus of claim 27, wherein the manifold extends through the wall of the nerve conduit in fluid communication with the luminal space. 41. The apparatus of claim 27, wherein the scaffold is formed from a foam or gel material. 42. The apparatus of claim 27, wherein the scaffold comprises a bioactive agent. 43. The apparatus of claim 42, wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor. 44. The apparatus of claim 42, wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF). 45. The apparatus of claim 27, wherein the nerve conduit comprises a slice along its length that forms an opening whereby the nerve conduit is implantable around the tissue site and sealable with one or more closure elements. 46. The apparatus of claim 27, wherein the nerve conduit is composed of a bioinert material. 47. The apparatus of claim 27, wherein the nerve conduit is composed of a bioabsorbable material. 48. The apparatus of claim 47, wherein the nerve conduit is composed of collagen. 49. The apparatus of claim 27, wherein the nerve conduit comprises pores. 50. The apparatus of claim 49, wherein the pores are sufficiently small to exclude the entry of cells from tissue surrounding the nerve conduit into the luminal space. 51. The apparatus of claim 50, wherein the pores have a diameter of between about 5 μm and about 50 μm.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (89)
Ward William J. (Hull GBX) Shorthouse Joanne (Hull GBX), Adhesive dressing for retaining a cannula on the skin.
Errede Louis A. (North Oaks MN) Stoesz James D. (St. Paul MN) Winter ; deceased George D. (late of St. Paul MN by Jenny Upton ; personal representative), Composite wound dressing.
Todd Robert J. (Salt Lake City UT) Yagge Jaime E. (Salt Lake City UT) Lowe James E. (Durham NC) Wonder Terry M. (Salt Lake City UT), Medical suction apparatus.
Ferdman Ariel (12 Hillside Ave. Melrose MA 02176) Kuo Jing-wen (Boxboro MA) Miller David (Brookline MA) Pinsky Vladimir (Brighton MA) Richards William D. (Medway MA) Swann David (Cambridge MA), Method and device for wound closure.
Moriuchi Yousuke (Fujinomiya JPX) Ishida Toshinobu (Fujinomiya JPX) Kousai Tadashi (Fujinomiya JPX), Method of securing a catheter body to a human skin surface.
Luheshi Abdul B. N. (Hull GB3) Smalley Robert K. (Urmston GB3) Kennewell Peter D. (Okus GB3) Westwood Robert (Kingston Bagpuize GB3), Process for the preparation of azabicyclo compounds.
Kashmer James S. (Budd Lake NJ) Klimbach John K. (Wayne NJ) Vendetti Randall P. (Lincoln Park NJ), Suction canister with unitary shut-off valve and filter features.
Richmond James W. (Kalamazoo MI) Tice Robert G. (Portage MI) Booth ; III William M. (Paw Paw MI), Vacuum wound drainage system and lipids baffle therefor.
McNeil Charles B. (5960 Arbour Ave. Edina MN 55436) McEvoy Thomas J. (13103 Baker Trail Minnetonka MN 55343), Wearable, variable rate suction/collection device.
Lock Peter M. (327 Lordswood La. Petrosa ; Walderslade ; Chatham ; Kent GB2) Webb David R. (9 Lambourn Way Lordwood ; Chatham ; Kent GB2), Wound dressing materials.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.